Into the wild: simian immunodeficiency virus (SIV) infection in natural hosts

Trends in Immunology

Volumn 29, Issue 9, 2008, Pages 419-428

  Pandrea, Ivona ^a,b   Sodora, Donald L ^c   Silvestri, Guido ^d   Apetrei, Cristian ^a,e  

^a TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e TULANE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOLOGY; IMMUNOREACTIVITY; LYMPHOCYTE DEPLETION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MUCOSA; NATURAL HOST; NONHUMAN; PATHOGENESIS; PERITONEUM; REVIEW; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; VIRUS INFECTION; VIRUS REPLICATION; VIRUS RESISTANCE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; HIV INFECTIONS; HUMANS; IMMUNITY; MODELS, IMMUNOLOGICAL; PRIMATES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 49849088558     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2008.05.004     Document Type: Review

References (79)

1. Sekaly R.P. The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?. J. Exp. Med. 205 (2008) 7-12
2. VandeWoude S., and Apetrei C. Going wild: lessons from T-lymphotropic naturally occurring lentiviruses. Clin. Microbiol. Rev. 19 (2006) 728-762
3. Silvestri G., et al. Understanding the benign nature of SIV infection in natural hosts. J. Clin. Invest. 117 (2007) 3148-3154
4. Apetrei C., et al. Direct inoculation of simian immunodeficiency virus from sooty mangabeys in black mangabeys (Lophocebus aterrimus): first evidence of AIDS in a heterologous African species and different pathologic outcomes of experimental infection. J. Virol. 78 (2004) 11506-11518
5. Ling B., et al. Classic AIDS in a sooty mangabey after an 18-year natural infection. J. Virol. 78 (2004) 8902-8908
6. Pandrea I., et al. Chronic SIV infection ultimately causes immunodeficiency in African non-human primates. AIDS 15 (2001) 2461-2462
7. Keele B.F., et al. Chimpanzee reservoirs of pandemic and nonpandemic HIV-1. Science 313 (2006) 523-526
8. Van Heuverswyn F., et al. Human immunodeficiency viruses: SIV infection in wild gorillas. Nature 444 (2006) 164
9. Gordon S., et al. The call of the wild: what can be learned from studies of SIV infection of natural hosts?. In: Leitner T., et al. (Ed). HIV Sequence Compendium 2004 (2005), Theoretical Biology and Biophysics Group, Los Alamos National Laboratory 2-29
10. Silvestri G. Naturally SIV-infected sooty mangabeys: are we closer to understanding why they do not develop AIDS?. J. Med. Primatol. 34 (2005) 243-252
11. Apetrei C., et al. Molecular epidemiology of SIVsm in US Primate Centers unravels the origin of SIVmac and SIVstm. J. Virol. 79 (2005) 8991-9005
12. Apetrei C., et al. Kuru experiments triggered the emergence of pathogenic SIVmac. AIDS 20 (2006) 317-321
13. Beer B.E., et al. Immunodeficiency in the absence of high viral load in pig-tailed macaques infected with simian immunodeficiency virus SIVsun and SIVlhoest. J. Virol. 79 (2005) 14044-14056
14. Souquière, S. et al. SIVmnd-1 and SIVmnd-2 have different pathogenic potentials in Rhesus macaques upon experimental cross-species transmission. J. Gen. Virol. (in press)
15. Pandrea I., et al. Simian immunodeficiency virus (SIV) SIVagm.sab infection of Caribbean African green monkeys: New model of the study of SIV pathogenesis in natural hosts. J. Virol. 80 (2006) 4858-4867
16. Apetrei C., et al. Virus subtype-specific features of natural simian immunodeficiency virus SIVsmm infection in sooty mangabeys. J. Virol. 81 (2007) 7913-7923
17. Broussard S.R., et al. Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease. J. Virol. 75 (2001) 2262-2275
18. Diop O.M., et al. High levels of viral replication during primary simian immunodeficiency virus SIVagm infection are rapidly and strongly controlled in African green monkeys. J. Virol. 74 (2000) 7538-7547
19. Gordon S.N., et al. Severe depletion of mucosal CD4+ T cells in AIDS-free simian immunodeficiency virus-infected sooty mangabeys. J. Immunol. 179 (2007) 3026-3034
20. Gueye A., et al. Viral load in tissues during the early and chronic phase of non-pathogenic SIVagm infection. J. Med. Primatol. 33 (2004) 83-97
21. Onanga R., et al. High levels of viral replication contrast with only transient changes in CD4+ and CD8+ cell numbers during the early phase of experimental infection with simian immunodeficiency virus SIVmnd-1 in Mandrillus sphinx. J. Virol. 76 (2002) 10256-10263
22. Onanga R., et al. Primary simian immunodeficiency virus SIVmnd-2 infection in mandrills (Mandrillus sphinx). J. Virol. 80 (2006) 3301-3309
23. Pandrea I., et al. Simian immunodeficiency virus SIVagm.sab infection of Caribbean African green monkeys: a new model for the study of SIV pathogenesis in natural hosts. J. Virol. 80 (2006) 4858-4867
24. Pandrea I., et al. High levels of SIVmnd-1 replication in chronically infected Mandrillus sphinx. Virology 317 (2003) 119-127
25. Pandrea I., et al. Simian immunodeficiency virus SIVagm dynamics in African green monkeys. J. Virol. 82 (2008) 3713-3724
26. Pandrea I., et al. Simian immunodeficiency viruses replication dynamics in African non-human primate hosts: common patterns and species-specific differences. J. Med. Primatol. 35 (2006) 194-201
27. Pandrea I.V., et al. Acute loss of intestinal CD4+ T cells is not predictive of simian immunodeficiency virus virulence. J. Immunol. 179 (2007) 3035-3046
28. Silvestri G., et al. Divergent host responses during primary simian immunodeficiency virus SIVsm infection of natural sooty mangabey and nonnatural rhesus macaque hosts. J. Virol. 79 (2005) 4043-4054
29. Goldstein S., et al. Wide range of viral load in healthy African green monkeys naturally infected with simian immunodeficiency virus. J. Virol. 74 (2000) 11744-11753
30. Pandrea I., et al. Impact of viral factors on very early in vivo replication profiles in simian immunodeficiency virus SIVagm-infected African green monkeys. J. Virol. 79 (2005) 6249-6259
31. Goldstein S., et al. Comparison of simian immunodeficiency virus SIVagmVer replication and CD4+ T-cell dynamics in vervet and sabaeus African green monkeys. J. Virol. 80 (2006) 4868-4877
32. Silvestri G., et al. Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity 18 (2003) 441-452
33. Kornfeld C., et al. Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. J. Clin. Invest. 115 (2005) 1082-1091
34. Milush J.M., et al. Virally induced CD4+ T cell depletion is not sufficient to induce AIDS in a natural host. J. Immunol. 179 (2007) 3047-3056
35. Sumpter B., et al. Correlates of preserved CD4(+) T cell homeostasis during natural, nonpathogenic simian immunodeficiency virus infection of sooty mangabeys: implications for AIDS pathogenesis. J. Immunol. 178 (2007) 1680-1691
36. Rodriguez B., et al. Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection. J. Am. Med. Assoc. 296 (2006) 1498-1506
37. Pandrea I., et al. Paucity of CD4+CCR5+ T cells is a typical feature of natural SIV hosts. Blood 109 (2007) 1069-1076
38. Li Q., et al. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 434 (2005) 1148-1152
39. Mattapallil J.J., et al. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434 (2005) 1093-1097
40. Mehandru S., et al. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J. Exp. Med. 200 (2004) 761-770
41. Mehandru S., et al. Mechanisms of gastrointestinal CD4+ T-cell depletion during acute and early human immunodeficiency virus type 1 infection. J. Virol. 81 (2007) 599-612
42. Veazey R.S., et al. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 280 (1998) 427-431
43. Pandrea I., et al. Paucity of CD4+CCR5+ T-cells may prevent breastfeeding transmission of SIV in natural non-human primate hosts. J. Virol. 82 (2008) 5501-5509
44. Dunham R., et al. The AIDS resistance of naturally SIV-infected sooty mangabeys is independent of cellular immunity to the virus. Blood 108 (2006) 209-217
45. Wang Z., et al. Th-1-type cytotoxic CD8+ T-lymphocyte responses to simian immunodeficiency virus (SIV) are a consistent feature of natural SIV infection in sooty mangabeys. J. Virol. 80 (2006) 2771-2783
46. Hirsch V.M. What can natural infection of African monkeys with simian immunodeficiency virus tell us about the pathogenesis of AIDS?. AIDS Rev. 6 (2004) 40-53
47. Brenchley J.M., et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 200 (2004) 749-759
48. Gordon S.N., et al. Short-lived infected cells support virus replication in sooty mangabeys naturally infected with simian immunodeficiency virus: implications for AIDS pathogenesis. J. Virol. 82 (2008) 3725-3735
49. Saez-Cirion A., et al. HIV controllers: how do they tame the virus?. Trends Immunol. 28 (2007) 532-540
50. Vanderford T.H., et al. Adaptation of a diverse simian immunodeficiency virus population to a new host is revealed through a systematic approach to identify amino acid sites under selection. Mol. Biol. Evol. 24 (2007) 660-669
51. Muller M.C., and Barre-Sinoussi F. SIVagm: genetic and biological features associated with replication. Front. Biosci. 8 (2003) d1170-d1185
52. Demma L.J., et al. Evolution of the uniquely adaptable lentiviral envelope in a natural reservoir host. Retrovirology 3 (2006) 19
53. Klatt N.R., et al. Availability of activated CD4+ T-cells dictates the level of viremia in naturally SIV-infected sooty mangabeys. J. Clin. Invest. 118 (2008) 2039-2049
54. Perelson A.S. Modelling viral and immune system dynamics. Nat. Rev. Immunol. 2 (2002) 28-36
55. Sodora D.L., and Silvestri G. Immune activation and AIDS pathogenesis. AIDS 22 (2008) 439-446
56. Kovacs J.A., et al. Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV. J. Exp. Med. 194 (2001) 1731-1741
57. Mohri H., et al. Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy. J. Exp. Med. 194 (2001) 1277-1287
58. Hazenberg M.D., et al. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 17 (2003) 1881-1888
59. Giorgi J.V., et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J. Infect. Dis. 179 (1999) 859-870
60. Sousa A.E., et al. CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J. Immunol. 169 (2002) 3400-3406
61. Deeks S.G., et al. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 104 (2004) 942-947
62. Ploquin M.J., et al. Distinct expression profiles of TGF-beta1 signaling mediators in pathogenic SIVmac and non-pathogenic SIVagm infections. Retrovirology 3 (2006) 37
63. Cumont M.C., et al. Early divergence in lymphoid tissue apoptosis between pathogenic and nonpathogenic simian immunodeficiency virus infections of nonhuman primates. J. Virol. 82 (2008) 1175-1184
64. Hurtrel B., et al. Apoptosis in SIV infection. Cell Death Differ. 12 Suppl 1 (2005) 979-990
65. Grossman Z., et al. Pathogenesis of HIV infection: what the virus spares is as important as what it destroys. Nat. Med. 12 (2006) 289-295
66. Picker L.J., et al. Insufficient production and tissue delivery of CD4+ memory T cells in rapidly progressive simian immunodeficiency virus infection. J. Exp. Med. 200 (2004) 1299-1314
67. Muthukumar A., et al. Timely triggering of homeostatic mechanisms involved in the regulation of T-cell levels in SIVsm-infected sooty mangabeys. Blood 106 (2005) 3839-3845
68. Chakrabarti L.A., et al. Normal T-cell turnover in sooty mangabeys harboring active simian immunodeficiency virus infection. J. Virol. 74 (2000) 1209-1223
69. Kaur A., et al. Dynamics of T- and B-lymphocyte turnover in a natural host of simian immunodeficiency virus. J. Virol. 82 (2008) 1084-1093
70. Herbein G., and Khan C.A. Is HIV infection a TNF receptor signalling-driven disease?. Trends Immunol. 29 (2008) 61-67
71. Kosub D.A., et al. Gamma/Delta T-cell functional responses differ after pathogenic human immunodeficiency virus and nonpathogenic simian immunodeficiency virus infections. J. Virol. 82 (2008) 1155-1165
72. Rutjens E., et al. Differential NKp30 inducibility in chimpanzee NK cells and conserved NK cell phenotype and function in long-term HIV-1-infected animals. J. Immunol. 178 (2007) 1702-1712
73. Diop O.M., et al. Plasmacytoid dendritic cell dynamics and alpha interferon production during simian immunodeficiency virus infection with a nonpathogenic outcome. J. Virol. 82 (2008) 5145-5152
74. Brenchley J.M., et al. HIV disease: fallout from a mucosal catastrophe?. Nat. Immunol. 7 (2006) 235-239
75. Brenchley J.M., et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12 (2006) 1365-1371
76. Ferrick D.A., et al. Differential production of interferon-gamma and interleukin-4 in response to Th1- and Th2-stimulating pathogens by gamma delta T cells in vivo. Nature 373 (1995) 255-257
77. Martini F., et al. Acute human immunodeficiency virus replication causes a rapid and persistent impairment of Vgamma9Vdelta2 T cells in chronically infected patients undergoing structured treatment interruption. J. Infect. Dis. 186 (2002) 847-850
78. Poggi A., et al. Migration of V delta 1 and V delta 2 T cells in response to CXCR3 and CXCR4 ligands in healthy donors and HIV-1-infected patients: competition by HIV-1 Tat. Blood 103 (2004) 2205-2213
79. Schindler M., et al. Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell 125 (2006) 1055-1067